SCHEMBL4047718

SCHEMBL4047718

COC(=O)C1Cc2c([nH]c3ccccc23)C(c2cc(C)ccc2OC)N1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 2/20 0.71
PDE5A O76074 5/20 0.67
KDM4E B2RXH2 4/20 0.62
HSD17B10 Q99714 2/20 0.62
TSHR P16473 2/20 0.62
HTT P42858 1/20 0.62
ALDH1A1 P00352 4/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
ALOX12 P18054 1/20 0.59
CYP2D6 P10635 3/20 0.57
CYP2C19 P33261 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HDAC1 Q13547 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
CYP1A2 P05177 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14122016 0.90 PDE5A (0.67) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL14121883 0.90 PDE5A (0.67) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL14121446 0.90 PDE5A (0.67) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL14122143 0.90 PDE5A (0.67) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL5033704 0.88 PDE5A (0.64) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL17760585 0.88 CCKBR (0.74) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL17760612 0.88 CCKBR (0.74) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL17760566 0.86 PDE5A (0.83) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL17760547 0.86 PDE5A (0.83) CCKBRPDE5AKDM4EHSD17B10TSHR
SCHEMBL17760548 0.85 PDE5A (0.69) CCKBRPDE5AKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024613-A1 TETRACYCLIC INDOLOPYRIDINES AS EG5 INHIBITORS 4SC AG (DE) 2009-02-26 WO disclosed